Serum Institute of India seeks indemnity against liabilities: Sources
https://ift.tt/3pjfv7E
Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.
Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.
No comments